Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Globalisation


When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.


AZ for $100bn? Pfizer could buy Azerbaijan and keep the change

22-Apr-2014 - With Pfizer rumoured to be on the brink of a mega-merger with AstraZeneca, brings you an interactive view of what £60bn ($101bn) could get.

US to lose 140,000 jobs if status quo is maintained, PhRMA reports

18-Apr-2014 - Biopharma executives believe there will be strong growth in domestic R&D activities and biopharma manufacturing, but fewer workers will be needed as efficiencies in productivity are achieved across the industry,...

Novartis eyes Asian market with $160m Singapore ophthalmic plant

15-Apr-2014 - Novartis subsidiary Alcon has opened the doors to its new $160m facility in Singapore for the manufacture of ophthalmic drugs.

Governments urged to rethink stockpiling after Tamiflu and Relenza reviewed

10-Apr-2014 - Tamiflu shortens the duration of influenza symptoms by only half a day, does not stop person-to-person spread and increases the risk of nausea say the authors of a new review...

Lupin: Mexican buy a bridgehead to generics and API growth

01-Apr-2014 - Lupin has bought Mexican eye drugmaker Grin in a deal that gives it a “bridgehead” to grow its API and generics business in the region.

GSK to invest $166m in manufacturing in Sub-Saharan Africa

31-Mar-2014 - GSK says it intends to build five new drug manufacturing as part of a £130m ($215m) investment in sub-Saharan Africa.

Hospira edges closer to completion of Orchid API deal in India

18-Mar-2014 - The Board of Directors at Indian firm Orchid has approved the sale of its API business to Hospira, bringing the acquisition a step closer to completion.

Opportunities outweigh risks in China, says Eli Lilly

17-Mar-2014 - Eli Lilly says the opportunities in China outweigh any perceived challenges as it begins a $70m expansion of its manufacturing joint venture.

Pfizer invests in Indonesian solid dose facility

11-Mar-2014 - Pfizer’s $3.5m expansion of an Indonesian solid oral dose plant will increase capacity by 76%, the company says.

‘New’ Ranbaxy generic Lipitor recall took place in January

10-Mar-2014 - Publication of a US FDA enforcement report detailing a recall by Ranbaxy in January saw the beleaguered Indian drugmakers’ share price fall 3% last week.

Bayer looks to grow Chinese OTC business with Dihon acquisition

03-Mar-2014 - Bayer has predicted double digit growth in its Chinese consumer health business as it acquires OTC firm Dihon Pharmaceutical Group.

NIH partners with 10 pharma companies to tackle major disease targets

11-Feb-2014 - The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s...

Off-the-shelf aseptic manufacturing? Pfizer targets emerging markets in JV

10-Feb-2014 - Pfizer says its ‘off the shelf’ aseptic processing capacity is shifting the paradigm of pharma manufacturing, with emerging markets and personalised medicine driving the change.

Johnson Matthey's controlled API biz sees positive Q3 sales after restructure

04-Feb-2014 - Johnson Matthey's decision to restructure its narcotic API business in light of increased UK competition has paid off, the company says.

Productivity drive could affect up to 4,000 Novartis jobs in 2014

03-Feb-2014 - Novartis has confirmed that pharma jobs will be reallocated in 2014 in a continuation of the productivity drive that saved the firm $2.8bn (EUR2bn) last year.  

Hospira intent on growing Indian ops as EU market beckons

23-Jan-2014 - Increased in-house API production and manufacturing in India will lower the costs of Hospira’s injectables, the firm says, as it looks past current remediation efforts.


EU reliance on API imports is 'alarming' says EFCG

21-Jan-2014 - European dependence on drugs and APIs made outside the EU is still ‘alarming’ despite recently introduced anti-falsified meds laws according to the European Fine Chemicals Group (EFCG).

US FDA poised to up China inspections after favourable FY14 budget

20-Jan-2014 - The US FDA is positioned to increase drug plant inspections in China after US President Barack Obama signed a $1.1tr (€881bn) budget for fiscal 2014 into law on Saturday.

Complex generics will boost speciality biz, Teva says

16-Jan-2014 - Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business.

A QP for GMP? That is the suggestion: IRCA launches pharma auditor training

16-Jan-2014 - GMP auditors need a professional qualification similar to QP status according to a group whose new training scheme is designed to create a competency benchmark.

Hospitals wont buy drugs from firms on bribery blacklist says China Gov

02-Jan-2014 - Chinese regulators plan to 'blacklist' drugmakers involved in bribery along with those that make 'shoddy' pharmaceuticals.


Shasun to sell Vizag API plant

12-Dec-2013 - Drug ingredient supplier Shasun Pharmaceuticals has announced its intention to sell its API plant in Vizag, India.

Puerto Rico must address rising costs to ensure pharma future, says expert

10-Dec-2013 - Puerto Rico’s drug manufacturing industry has no future unless utility costs and taxes are controlled, according to a regulatory expert.

Hospira: In-house API production to reach 50% by 2018 through acquisitions

09-Dec-2013 - Hospira says it intends to up in-house manufacture of its APIs from 10 to 50% by 2018 as it awaits completion of last year’s acquisition of Orchid.

US FDA sued for alleged 'unlawful' detention of API batch destined for CMO

05-Dec-2013 - A lawsuit alleging that the US FDA unlawfully detained a batch of acetaminophen API destined for CMO Gemini Pharmaceuticals could have significant impact on the drug industry's definition of an...

Key Industry Events


Access all events listing

Our events, Events from partners...